PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16521213-10	2006	When only the data from the 11 patients treated with anthraquinone drug, mitoxantrone, were analyzed, however, the number of patients who showed poor response to treatment was significantly higher among the p53-positive patients (P=0.012), irrespective of the survival outcome.	Anthraquinones	53-66	tumor protein p53	Homo sapiens	207-210	
16521213-12	2006	Similarly, immunostaining to evaluate p53 protein may be useful to predict the response in patients treated with an anthraquinone drug.	Anthraquinones	116-129	tumor protein p53	Homo sapiens	38-41